← Leaderboards
Lori A Emert-Sedlak
University Of Pittsburgh At Pittsburgh
$155,166
Attributed
$155,166
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $53.8K · FY2008–10$100K$75K$50K$25K$0
'08
'09
'10
Funding mix
By agency
NIH$155,166 · 1
By mechanism
F32$155,166 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Thomas Edward Smithgall$26,440,514
- Charles R Rinaldo$100,535,685
- John W Mellors$70,850,753
- Lori A Birder$16,985,823
- Anthony John Kanai$13,693,260
Others in their field
Top investigators on “Drug Delivery Systems”
- Wafaa M. El-Sadr · Columbia University Health Sciences$101,800,876
- Myron S Cohen · Family Health International$101,800,876
- Gerald Van Belle · University Of Washington$48,120,734
- David Heimbrook · Leidos Biomedical Research, Inc.$47,325,954
- Henry Shelton Earp · Univ Of North Carolina Chapel Hill$38,382,452
- Martin Friedlander · Scripps Research Institute$36,319,942
Research focus
Drug Delivery SystemsDrug DevelopmentAnalogAids/Hiv ProblemAcquired Immunodeficiency SyndromeAllelesAstrocytomaBinding (Molecular Function)Binding ProteinsAnti-Hiv AgentsBiotinAnti-Retroviral AgentsCell LineCell ModelCellsCell TypeCellular TargetingChimera OrganismClinically RelevantComplexBiological ModelsDisease ProgressionDown-RegulationDrug Discovery
Grant awards (3)
Complexes of HIV-1 Nef with Src-family Kinases as Therapeutic Targets$53,810
F32 · FY2010 · AI · contact PI
Complexes of HIV-1 Nef with Src-family Kinases as Therapeutic Targets$51,710
F32 · FY2009 · AI · contact PI
Complexes of HIV-1 Nef with Src-family Kinases as Therapeutic Targets$49,646
F32 · FY2008 · AI · contact PI